Biyun Wang, MD
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Chidamide in Combination With Abemaciclib and Endocrinotherapy（Doctor's Choice） in Breast Cancer Patients Previously Treated With Palbociclib (NCT05464173) | Biyun Wang, MD | 2022-07-01 |
| 18F-FDG Uptake Heterogeneity Predicts Pyrotinib Response (NCT04756921) | Biyun Wang, MD | 2018-09-01 |
Track Biyun Wang, MD automatically
Every clearance here is in the API, with alerts when new ones post.